CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Hydroxychloroquine + AzithromycinWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)


Name (Synonyms) Correlation
drug766 Standard Plasma (FFP) Wiki 1.00
drug363 Hydroxychloroquine + Placebo Wiki 1.00
drug349 High-Titer COVID-19 Convalescent Plasma (HT-CCP) Wiki 1.00
drug618 Placebo + Placebo Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D003141 Communicable Diseases NIH 0.12
D007239 Infection NIH 0.08

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Qatar Prospective RCT Of Therapy Eliminating Covid Transmission

Q-PROTECT is a placebo controlled randomized trial (RCT) to ascertain the efficacy of hydroxychloroquine (HC) alone or, in combination with azithromycin (AZ), in reducing viral load in patients with COVID 19.

NCT04349592 Covid19 Drug: Hydroxychloroquine + Azithromycin Drug: Hydroxychloroquine + Placebo Other: Placebo + Placebo

Primary Outcomes

Description: Days

Measure: Proportion of virologically cured (no virus detected) cases at day 6

Time: Day 6

Secondary Outcomes

Description: Days

Measure: The dichotomous virologic shedding endpoint as assessed at two weeks after study entry

Time: 2 weeks

Description: Days

Measure: Quantitative viral load (assessed with each virology testing set)

Time: Day 1 to 21


No related HPO nodes (Using clinical trials)